188 related articles for article (PubMed ID: 27910734)
1. Targeting the AKT/cyclin D1 pathway to overcome intrinsic and acquired radioresistance of tumors for effective radiotherapy.
Shimura T
Int J Radiat Biol; 2017 Apr; 93(4):381-385. PubMed ID: 27910734
[TBL] [Abstract][Full Text] [Related]
2. Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle.
Shimura T
J Radiat Res; 2011; 52(5):539-44. PubMed ID: 21881296
[TBL] [Abstract][Full Text] [Related]
3. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
4. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression.
Shimura T; Kakuda S; Ochiai Y; Nakagawa H; Kuwahara Y; Takai Y; Kobayashi J; Komatsu K; Fukumoto M
Oncogene; 2010 Aug; 29(34):4826-37. PubMed ID: 20562919
[TBL] [Abstract][Full Text] [Related]
5. Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells.
Shimura T; Noma N; Oikawa T; Ochiai Y; Kakuda S; Kuwahara Y; Takai Y; Takahashi A; Fukumoto M
Oncogenesis; 2012 Jun; 1(6):e12. PubMed ID: 23552696
[TBL] [Abstract][Full Text] [Related]
6. AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells.
Shimura T; Noma N; Sano Y; Ochiai Y; Oikawa T; Fukumoto M; Kunugita N
Radiother Oncol; 2014 Aug; 112(2):302-7. PubMed ID: 25150637
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells.
Shimura T; Ochiai Y; Noma N; Oikawa T; Sano Y; Fukumoto M
Cell Cycle; 2013 Mar; 12(5):773-82. PubMed ID: 23388457
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway.
Xu Z; Yan Y; Xiao L; Dai S; Zeng S; Qian L; Wang L; Yang X; Xiao Y; Gong Z
PLoS One; 2017; 12(4):e0175977. PubMed ID: 28414793
[TBL] [Abstract][Full Text] [Related]
10. MiR-139 Affects Radioresistance in Esophageal Cancer by Targeting the PDK1/AKT/Cyclin D1 Signaling Pathway.
Liu Y; Liu Y; Jiao WP
Bull Exp Biol Med; 2023 Feb; 174(4):489-496. PubMed ID: 36899199
[TBL] [Abstract][Full Text] [Related]
11. Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas.
Milas L; Akimoto T; Hunter NR; Mason KA; Buchmiller L; Yamakawa M; Muramatsu H; Ang KK
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):514-21. PubMed ID: 11872299
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
13. Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.
Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y
Crit Rev Oncol Hematol; 2015 Dec; 96(3):507-17. PubMed ID: 26253360
[TBL] [Abstract][Full Text] [Related]
14. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial reactive oxygen species perturb AKT/cyclin D1 cell cycle signaling via oxidative inactivation of PP2A in lowdose irradiated human fibroblasts.
Shimura T; Sasatani M; Kamiya K; Kawai H; Inaba Y; Kunugita N
Oncotarget; 2016 Jan; 7(3):3559-70. PubMed ID: 26657292
[TBL] [Abstract][Full Text] [Related]
16. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
[TBL] [Abstract][Full Text] [Related]
17. Nanog Signaling Mediates Radioresistance in ALDH-Positive Breast Cancer Cells.
Dehghan Harati M; Rodemann HP; Toulany M
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845764
[TBL] [Abstract][Full Text] [Related]
18. α-Actinin-4 confers radioresistance coupled invasiveness in breast cancer cells through AKT pathway.
Desai S; Barai A; Bukhari AB; De A; Sen S
Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):196-208. PubMed ID: 29055790
[TBL] [Abstract][Full Text] [Related]
19. MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer.
Zheng L; Zhang Y; Liu Y; Zhou M; Lu Y; Yuan L; Zhang C; Hong M; Wang S; Li X
J Transl Med; 2015 Aug; 13():252. PubMed ID: 26238857
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells.
Su H; Jin X; Shen L; Fang Y; Fei Z; Zhang X; Xie C; Chen X
Tumour Biol; 2016 Apr; 37(4):5355-63. PubMed ID: 26561473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
